| Identification | Back Directory | [Name]
Sitagliptin Impurity 21 | [CAS]
2088771-60-0 | [Synonyms]
2088771-60-0
Sitagliptin-14
Sitagliptin FP Impurity A
Sitagliptin Impurity FP-A
USPSitagliptinFumarateadduct
2-(((R)-4-oxo-4-(3-(trifluoromethyl)
Sitagliptin Tablets EP Impurity FP-A
Sitagliptin Fumarate Adduct Impurity
Sitagliptin Fumarate Adduct(Sitagliptin Impurity FP-A)
(R)-Sitagliptin rac-Fumarate Adduct (mixture of diastereomers)
Sitagliptin FP Impurity A/ Sitagliptin Fumarate Adduct/ Sitagliptin Maleate Adduct
((R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo [4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl) aspartic acid
2-{[(2R)-4-oxo-4-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]amino}butanedioic acid
L-Aspartic acid, N-[(1R)-3-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]-
Sitagliptin impurity 5/Sitagliptin FP Impurity A/Sitagliptin Fumarate Adduct/Sitagliptin Maleate Adduct/N-[(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]aspartic acid | [Molecular Formula]
C20H19F6N5O5 | [MDL Number]
MFCD33550932 | [MOL File]
2088771-60-0.mol | [Molecular Weight]
523.39 |
| Chemical Properties | Back Directory | [Melting point ]
149 - 153°C | [Boiling point ]
673.9±65.0 °C(Predicted) | [density ]
1.66±0.1 g/cm3(Predicted) | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
2.05±0.23(Predicted) | [color ]
White to Off-White |
| Hazard Information | Back Directory | [Uses]
Sitagliptin Fumarate Adduct is an impurity of Sitagliptin (S491000), a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes. |
|
| Company Name: |
Molsyns Research
|
| Tel: |
+91-9586858886 +91-9586858886 |
| Website: |
www.molsyns.com |
|